General MedicationsINTRAVENOUSStandard
PARICALCITOL
PARICALCITOL
Standard Dose
0.005MG/ML (0.005MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PARICALCITOL is listed in Drugs@FDA under application 207174 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PARICALCITOL Form and strength SOLUTION;INTRAVENOUS - 0.005MG/ML (0.005MG/ML) Sponsor ACCORD HLTHCARE Submission history Latest submission status date: 2019-10-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview PARICALCITOL is listed in Drugs@FDA under application 207174 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PARICALCITOL Form and strength SOLUTION;INTRAVENOUS - 0.005MG/ML (0.005MG/ML) Sponsor ACCORD HLTHCARE Submission history Latest submission status date: 2019-10-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.